Alnylam Pharmaceuticals said this week that Vicki Sato has been elected to the company's board of directors.
Sato was formerly president of Vertex Pharmaceuticals. Before this, she served as the company's CSO and chief of the scientific advisory board. Prior to joining Vertex, she held various positions at Biogen.
She holds a BS, MS, and PhD from Harvard University.
Lentigen said last week that it has named three new members of its management team (see full story, this issue).